DK114832B - Fremgangsmåde til fremstilling af terapeutisk aktive 3β-hydroxy-16α-alkyl-δ<4>-pregnenderivater eller estere deraf. - Google Patents

Fremgangsmåde til fremstilling af terapeutisk aktive 3β-hydroxy-16α-alkyl-δ<4>-pregnenderivater eller estere deraf.

Info

Publication number
DK114832B
DK114832B DK531764AA DK531764A DK114832B DK 114832 B DK114832 B DK 114832B DK 531764A A DK531764A A DK 531764AA DK 531764 A DK531764 A DK 531764A DK 114832 B DK114832 B DK 114832B
Authority
DK
Denmark
Prior art keywords
pregnant
hydroxy
esters
derivatives
alkyl
Prior art date
Application number
DK531764AA
Other languages
English (en)
Inventor
C Hewett
G Woods
Original Assignee
Organon Labor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Labor Ltd filed Critical Organon Labor Ltd
Publication of DK114832B publication Critical patent/DK114832B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/003Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK531764AA 1963-10-28 1964-10-28 Fremgangsmåde til fremstilling af terapeutisk aktive 3β-hydroxy-16α-alkyl-δ<4>-pregnenderivater eller estere deraf. DK114832B (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB42374/63A GB1085612A (en) 1963-10-28 1963-10-28 New 16-alkyl pregnane derivatives and process for the preparation thereof
GB1604164 1964-04-17
GB3706464 1964-09-10

Publications (1)

Publication Number Publication Date
DK114832B true DK114832B (da) 1969-08-11

Family

ID=27257327

Family Applications (1)

Application Number Title Priority Date Filing Date
DK531764AA DK114832B (da) 1963-10-28 1964-10-28 Fremgangsmåde til fremstilling af terapeutisk aktive 3β-hydroxy-16α-alkyl-δ<4>-pregnenderivater eller estere deraf.

Country Status (8)

Country Link
US (1) US3325518A (da)
BE (1) BE654958A (da)
BR (1) BR6463668D0 (da)
CH (1) CH487879A (da)
DE (1) DE1468452A1 (da)
DK (1) DK114832B (da)
GB (1) GB1085612A (da)
NL (1) NL6412049A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1593058C3 (de) * 1966-08-06 1975-07-03 Merck Patent Gmbh, 6100 Darmstadt Salpha, 16alpha-Dimethyl-4-pregnen-3beta-ol-20-on, Verfahren zu dessen Herstellung sowie dieses enthaltende pharmazeutische Zubereitung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3061606A (en) * 1958-03-14 1962-10-30 Worcester Found Ex Biology Delta-4-pregnenolones and method

Also Published As

Publication number Publication date
BE654958A (da) 1965-04-28
US3325518A (en) 1967-06-13
NL6412049A (da) 1965-04-29
GB1085612A (en) 1967-10-04
DE1468452A1 (de) 1969-07-24
CH487879A (de) 1970-03-31
BR6463668D0 (pt) 1973-07-17

Similar Documents

Publication Publication Date Title
DK114344B (da) Fremgangsmåde til fremstilling af terapeutisk aktive alkyl- eller allylestere af 6,7-dialkoxy-3-kinolinkarboxylsyrer.
DK125421B (da) Analogifremgangsmåde til fremstilling af 5-substituerede-aza-dibenzo-cycloheptener eller syreadditionssalte deraf.
DK133372B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive hydroxy-cyclohexyl-aminer eller syreadditionssalte deraf.
DK112032B (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy- eller -acyloxy-Δ&lt;4&gt;-estrenderivater.
DK111113B (da) Fremgangsmåde til fremstilling af 3-methylflavon-8-carboxylsyre.
DK115400B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 3-keto-19-alkyl-androstaner.
DK120493B (da) Analogifremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.
DK119659B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme estere eller syreadditionssalte deraf.
DK121708B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 22-aza-cholestanderivater.
DK114207B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme phenylalaninderivater eller syreadditionssalte deraf.
DK125701B (da) Analogifremgangsmåde til fremstilling af N-monosubstituerede 1-aminoindaner eller syreadditionssalte deraf.
DK117632B (da) Fremgangsmåde til fremstilling af 3-alkyliden-Δ&lt;4&gt;-estrener.
DK118825B (da) Fremgangsmåde til fremstilling af adrenocorticotropt virksomme tricosa- eller tetracosapeptider.
DK103831C (da) Fremgangsmåde til fremstilling af 4-azathioxanthenderivater eller syreadditionssalte deraf.
DK118506B (da) Fremgangsmåde til fremstilling af 7-aminocephalosporansyre eller estere deraf.
DK116658B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ&lt;5&gt;-østrener.
DK112235B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 21-dicyclohexylmethylcarbonater af 21-hydroxy-Δ&lt;4&gt;-pregnen-17α-ol-3,20-dioner.
DK114832B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 3β-hydroxy-16α-alkyl-δ&lt;4&gt;-pregnenderivater eller estere deraf.
DK115842B (da) Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf.
DK118716B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 6α-methyl-16-methylen-Δ&lt;4&gt;-ostren-17β-oler eller estere deraf.
DK113585B (da) Analogifremgangsmåde til fremstilling af 15, 16β-methylen-3-keto-Δ&lt;4&gt;-19-nor-androsten-17β-oler eller estere deraf.
DK113149B (da) Fremgangsmåde til fremstilling af sulfamylanthranilsyrer.
DK114964B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme α-substituerede 1-naftylacetamider eller syreadditionssalte deraf.
DK121510B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ&lt;5(10)&gt;-østrener.
DK111957B (da) Fremgangsmåde til fremstilling af adamantylderivater af αhydroxy-carboxylsyrer.